Cite
Emergency Department Utilization for Patients Receiving Chimeric Antigen Receptor T Cell Infusion Therapy.
MLA
Qdaisat, Aiham, et al. “Emergency Department Utilization for Patients Receiving Chimeric Antigen Receptor T Cell Infusion Therapy.” Journal of Emergency Medicine (0736-4679), vol. 66, no. 1, Jan. 2024, p. e53. EBSCOhost, https://doi.org/10.1016/j.jemermed.2023.06.029.
APA
Qdaisat, A., Lipe, D. N., Chaftari, P., Wattana, M. K., Krishnamani, P. P., Reyes-Gibby, C., & Yeung, S.-C. J. (2024). Emergency Department Utilization for Patients Receiving Chimeric Antigen Receptor T Cell Infusion Therapy. Journal of Emergency Medicine (0736-4679), 66(1), e53. https://doi.org/10.1016/j.jemermed.2023.06.029
Chicago
Qdaisat, Aiham, Demis N. Lipe, Patrick Chaftari, Monica K. Wattana, Pavitra P. Krishnamani, Cielito Reyes-Gibby, and Sai-Ching J. Yeung. 2024. “Emergency Department Utilization for Patients Receiving Chimeric Antigen Receptor T Cell Infusion Therapy.” Journal of Emergency Medicine (0736-4679) 66 (1): e53. doi:10.1016/j.jemermed.2023.06.029.